Overview

Safety and Efficacy of Dexamethasone Ophthalmic Insert (Dextenza®) in the Management of Clinically Significant Dry Eye

Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
To determine efficacy and safety profile of dexamethasone 0.4mg lacrimal insert in dry eye related ocular surface inflammation.
Phase:
Phase 4
Details
Lead Sponsor:
Johns Hopkins University
Treatments:
Dexamethasone